The authors of "Combined treatment with HMGN1 and anti-CD4 depleti…" (https://t.co/ZjxHGiyEmJ) included RRIDs in their paper! RRIDs like this improve reproducibility in scientific research. #reproducibility #RRID
RT @sitcancer: #JITC Research: Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust a…
#JITC Research: Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice https://t.co/HB22oQrAhl https://t.co/fEdje6rV1v
#JITC Research: Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice https://t.co/HB22oQrAhl https://t.co/O6jsYdJq5G
#JITC Research: Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice https://t.co/HB22oQrAhl https://t.co/nzoz0dYlh6
Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and ... https://t.co/8oNscO3LjY
Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice. https://t.co/x2yOmusThn
RT @sitcancer: New #JITC Research: Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robu…
RT @sitcancer: New #JITC Research: Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robu…
New #JITC Research: Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice https://t.co/HB22oQrAhl https://t.co/DLYe0rIBny